ArticleAACE endocrinology and diabetes
Bardet-Biedl Syndrome in Four Siblings: Clinical and Genetic Insights From a Rare Familial Cluster.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy with multisystem involvement, including retinal dystrophy, obesity, polydactyly, renal anomalies, hypogonadism, and cognitive impairment. Early diagnosis is often delayed due to gradual symptom onset. The revised diagnostic criteria for BBS, considering molecular diagnosis, ensures diagnostic certainty. Case Report: We report a case of a 15-year-old girl born out of a nonconsanguineous marriage with delayed puberty, progressive vision loss, and obesity. Family history revealed similar symptoms in her 3 younger siblings. All four fulfilled diagnostic criteria for BBS. Whole exome sequencing in the index case and Sanger sequencing in the other 3 siblings identified a pathogenic homozygous 1 base pair deletion in exon 3 of the Discussion: BBS is a clinically and genetically heterogeneous disorder. Genetic confirmation aids early diagnosis, enabling timely intervention and multidisciplinary management to alleviate the burdensome complications. Conclusion: This case highlights the importance of early recognition and genetic confirmation in BBS, even in the background of nonconsanguinity. Early diagnosis can improve quality of life and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.